Promis Neurosciences Stock Price Prediction
| PMN Stock | USD 9.43 0.18 1.95% |
Momentum 52
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.34) | EPS Estimate Current Year (27.29) | EPS Estimate Next Year (10.96) | Wall Street Target Price 106.1045 | EPS Estimate Current Quarter (0.40) |
Using ProMIS Neurosciences hype-based prediction, you can estimate the value of ProMIS Neurosciences from the perspective of ProMIS Neurosciences response to recently generated media hype and the effects of current headlines on its competitors.
ProMIS Neurosciences Hype to Price Pattern
Investor biases related to ProMIS Neurosciences' public news can be used to forecast risks associated with an investment in ProMIS. The trend in average sentiment can be used to explain how an investor holding ProMIS can time the market purely based on public headlines and social activities around ProMIS Neurosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of ProMIS Neurosciences' market sentiment to its price can help taders to make decisions based on the overall investors consensus about ProMIS Neurosciences.
The fear of missing out, i.e., FOMO, can cause potential investors in ProMIS Neurosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying ProMIS because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ProMIS Neurosciences after-hype prediction price | USD 9.45 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out ProMIS Neurosciences Basic Forecasting Models to cross-verify your projections. ProMIS Neurosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of ProMIS Neurosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ProMIS Neurosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ProMIS Neurosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ProMIS Neurosciences Estimiated After-Hype Price Volatility
In the context of predicting ProMIS Neurosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ProMIS Neurosciences' historical news coverage. ProMIS Neurosciences' after-hype downside and upside margins for the prediction period are 3.63 and 15.27, respectively. We have considered ProMIS Neurosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ProMIS Neurosciences is not too volatile at this time. Analysis and calculation of next after-hype price of ProMIS Neurosciences is based on 3 months time horizon.
ProMIS Neurosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ProMIS Neurosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ProMIS Neurosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ProMIS Neurosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 5.82 | 0.02 | 0.02 | 3 Events / Month | 6 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
9.43 | 9.45 | 0.21 |
|
ProMIS Neurosciences Hype Timeline
On the 24th of January ProMIS Neurosciences is traded for 9.43. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of -0.02. ProMIS is expected to increase in value after the next headline, with the price projected to jump to 9.45 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.21%, whereas the daily expected return is at this time at -0.16%. The volatility of related hype on ProMIS Neurosciences is about 4013.79%, with the expected price after the next announcement by competition of 9.41. Total Income to common stockholders was 2.78 M with loss before taxes, overhead, and interest of (28.34 M). Considering the 90-day investment horizon the next expected press release will be in about 3 days. Check out ProMIS Neurosciences Basic Forecasting Models to cross-verify your projections.ProMIS Neurosciences Related Hype Analysis
Having access to credible news sources related to ProMIS Neurosciences' direct competition is more important than ever and may enhance your ability to predict ProMIS Neurosciences' future price movements. Getting to know how ProMIS Neurosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ProMIS Neurosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MPLT | MapLight Therapeutics Common | 0.34 | 4 per month | 4.28 | 0.02 | 8.62 | (7.89) | 39.27 | |
| ERNA | Eterna Therapeutics | (0.22) | 10 per month | 4.73 | 0.01 | 12.10 | (7.41) | 51.97 | |
| OSRH | OSR Holdings | 0.01 | 9 per month | 6.31 | 0.05 | 16.07 | (10.00) | 43.23 | |
| LPCN | Lipocine | (0.32) | 28 per month | 2.70 | 0.33 | 15.95 | (4.92) | 33.09 | |
| ADAP | Adaptimmune Therapeutics Plc | 0.14 | 3 per month | 15.04 | 0.03 | 22.82 | (18.18) | 168.52 | |
| EDSA | Edesa Biotech | 0.02 | 14 per month | 0.00 | (0.15) | 5.20 | (6.47) | 29.85 | |
| ANL | Adlai Nortye Ltd | (0.20) | 9 per month | 5.69 | 0.12 | 10.27 | (11.76) | 42.22 | |
| GOVX | GeoVax Labs | (0.93) | 10 per month | 0.00 | (0.26) | 9.38 | (13.70) | 42.89 | |
| THAR | Tharimmune | (0.32) | 18 per month | 5.26 | (0.0002) | 8.88 | (9.64) | 35.56 | |
| BRTX | BioRestorative Therapies | 0.03 | 9 per month | 0.00 | (0.11) | 6.36 | (5.93) | 37.70 |
ProMIS Neurosciences Additional Predictive Modules
Most predictive techniques to examine ProMIS price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ProMIS using various technical indicators. When you analyze ProMIS charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ProMIS Neurosciences Predictive Indicators
The successful prediction of ProMIS Neurosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ProMIS Neurosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ProMIS Neurosciences based on analysis of ProMIS Neurosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ProMIS Neurosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ProMIS Neurosciences's related companies. | 2025 | 2026 (projected) | Net Current Asset Value | 583.44 | 518.62 | Days Payables Outstanding | 246.67 | 259.0 |
Pair Trading with ProMIS Neurosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProMIS Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will appreciate offsetting losses from the drop in the long position's value.Moving against ProMIS Stock
| 0.81 | DSGN | Design Therapeutics | PairCorr |
| 0.78 | APGE | Apogee Therapeutics | PairCorr |
| 0.78 | SRRK | Scholar Rock Holding | PairCorr |
| 0.78 | CELC | Celcuity LLC | PairCorr |
| 0.7 | OBIO | Orchestra BioMed Holdings | PairCorr |
| 0.67 | DMAC | DiaMedica Therapeutics | PairCorr |
The ability to find closely correlated positions to ProMIS Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ProMIS Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ProMIS Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ProMIS Neurosciences to buy it.
The correlation of ProMIS Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProMIS Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProMIS Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ProMIS Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out ProMIS Neurosciences Basic Forecasting Models to cross-verify your projections. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.